Clinical trial
Modulation of Cerebral Grey Matter High Energy Phosphate Metabolites in Multiple Sclerosis by Dimethyl Fumarate
NCT02644083 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Modulation of Cerebral Grey Matter High Energy Phosphate Metabolites in Multiple Sclerosis by Dimethyl Fumarate
- Lead sponsor
- Oregon Health and Science University
- Phase
- Observational
- Overall status
- Terminated
- Start date
- February 29, 2016
- Completion date
- July 31, 2018
- Enrollment
- 4 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.